RLI Corp (NYSE: RLI) CEO granted stock options on 22,500 shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
RLI Corp chief executive officer Craig W. Kliethermes reported a compensation-related stock option grant. He received options covering 22,500 shares of common stock at an exercise price of $49.88 per share. The options expire on May 14, 2034 and vest in 20% increments annually, beginning one year after the grant date.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Kliethermes Craig W
Role
CHIEF EXECUTIVE OFFICER
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option | 22,500 | $0.00 | -- |
Holdings After Transaction:
Stock Option — 22,500 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Option grant size: 22,500 options
Exercise price: $49.88 per share
Expiration date: May 14, 2034
+2 more
5 metrics
Option grant size
22,500 options
Stock option grant to CEO covering 22,500 shares
Exercise price
$49.88 per share
Exercise price for newly granted stock options
Expiration date
May 14, 2034
Expiration of the CEO’s stock options
Vesting schedule
20% per year
Options may be exercised in 20% increments each year from one year after grant
Options held after grant
22,500 options
Total stock options from this grant following the reported transaction
Key Terms
Stock Option, exercise price, expiration date, grant/award acquisition, +1 more
5 terms
Stock Option financial
"security_title: "Stock Option""
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
exercise price financial
"conversion_or_exercise_price: "49.8800""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: "2034-05-14T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
grant/award acquisition financial
"transaction_action: "grant/award acquisition""
vesting schedule financial
"20% of the aggregate number of shares granted may be exercised commencing one year from grant date"
A vesting schedule is a timeline that determines when someone gains full ownership of certain benefits, such as company stock or retirement contributions. Think of it like earning the right to own a gift gradually over time, rather than receiving it all at once. It matters to investors because it affects when they can fully access or sell these benefits, influencing their financial planning and decision-making.
FAQ
What did RLI (RLI) CEO Craig Kliethermes report in this Form 4?
RLI CEO Craig W. Kliethermes reported receiving a stock option grant for 22,500 shares. These options are part of his compensation package and provide the right to buy RLI common stock at a fixed $49.88 exercise price before expiration in 2034.
What is the exercise price of the RLI (RLI) CEO’s new options?
The exercise price of the new options is $49.88 per share. This is the fixed price at which Craig W. Kliethermes may purchase RLI common stock under the grant, subject to the vesting schedule and the overall expiration date in May 2034.
When do Craig Kliethermes’ RLI (RLI) options vest and expire?
The options vest in 20% increments each year, starting one year after the grant date. This means full vesting over five years. All options expire on May 14, 2034, after which any unexercised portion can no longer be used to buy shares.